[非小细胞肺癌] 没有小细胞肺癌
1Division of Thoracic Oncology, Kobe Minimally Invasive Cancer Center.
Gan to kagaku ryoho. Cancer & chemotherapy
|August 23, 2023
概括
在非小细胞肺癌 (NSCLC) 中的寡聚转移 (Oligo-meta) 可能受益于局部治疗和标准治疗的结合. 将局部疗法与免疫检查点抑制剂相结合,有望在NSCLC寡头转移性疾病中增强治疗效果.
科学领域:
- 在瘤学瘤学.
- 癌症转移 癌症转移
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.4K
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
